SCHEMBL5118501

SCHEMBL5118501

Cc1ccccc1[C@H](O)CCc1c(C(=O)N(C)C)cc2c(nc(C)n2COCC[Si](C)(C)C)c1O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.33
CTSA P10619 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4962499 1.00 NPC1 (0.33) NPC1CTSA
SCHEMBL5109495 0.91 NPC1 (0.33) NPC1
SCHEMBL5109499 0.91 NPC1 (0.33) NPC1
SCHEMBL4963099 0.85 NPC1 (0.34) NPC1
SCHEMBL4965043 0.82 CTSA (0.33) CTSA
SCHEMBL4962050 0.82 CTSA (0.33) CTSA
SCHEMBL4962044 0.82 CTSA (0.33) CTSA
SCHEMBL4664638 0.82 F11 (0.37) NPC1
SCHEMBL4664634 0.82 NPC1 (0.36) NPC1
SCHEMBL4664726 0.79 KDM4E (0.34) CTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280855-A1 Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles NYCOMED GMBH (DE) 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280855-A1 Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles CYP1B1, CYP1A1, CYP3A4 NPC1 1421/4885CTSA 3031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.